{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-001034","form_type":"8-K","ticker":null,"cik":"0001409999","company_name":"Black Bird Biotech, Inc.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.099598+00:00","generated_at":"2026-06-05T03:38:44.834483+00:00","sec_items":["5.01","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Black Bird Biotech control changes to Nelson W. Grist; he becomes CEO","bullets":["Grist acquires ~55.95% of Series A Preferred from four directors for $75K (cash + notes).","Upon closing, Grist will hold ~46.83% voting control via ownership and voting agreement.","All current directors expected to resign; Grist to be sole Director.","Grist appointed CEO effective March 4, 2024; prior CEO of For the Earth Corp. and Perk International."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-001034","json":"https://secwatch.observer/filing/0001477932-24-001034.json","markdown":"https://secwatch.observer/filing/0001477932-24-001034.md","text":"https://secwatch.observer/filing/0001477932-24-001034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/0001477932-24-001034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/bbbt_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:38:44.834483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9dede2d559","claim":"Nelson W. Grist was appointed as Chief Executive Officer at Black Bird Biotech, Inc..","evidence_excerpt":"Effective March 4, 2024, the Board of Directors of the Company appointed Nelson W. Grist as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/0001477932-24-001034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"24e79d283a4fa7e1bae0269c9bedf3e2580e05c6","claim":"Black Bird Biotech, Inc. underwent a change of control involving Nelson W. Grist (closed 2024-03-15).","evidence_excerpt":"Upon the closing of the Series A Agreements, which is expected to occur on or after March 15, 2024.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/0001477932-24-001034-index.htm","confidence":0.4,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Nelson W. Grist"},{"label":"Closing","value":"2024-03-15"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}